There may be some debate as to whether activist shareholders are good for the long-term health of companies, but there is no debating their results. From 2012 through 2014, activist investment strategies returned 9.3%, 19.2%, and 8.5%. While new activist positions may not be moving the needle quite as much as they once were, the market still values activist involvement in companies. In this article, we reveal one of the latest activist filings, issued by Larry Robbins‘ Glenview Capital, detailing the latest information regarding their activist position in Tenet Healthcare Corp (NYSE:THC). The filing is embedded in its entirety below and on the following pages.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name || Sole Voting Power || Shared Voting Power || Sole Dispositive Power || Shared Dispositive Power || Aggregate Amount Owned Power || Percent of Class |
|GLENVIEW CAPITAL MANAGEMENT, LLC || 0 || 17,890,230 || 0 || 17,890,230 || 17,890,230 || 17.95% |
|LAWRENCE M. ROBBINS || 0 || 17,890,230 || 0 || 17,890,230 || 17,890,230 || 17.95% |
Larry RobbinsGlenview Capital
Page 1 of 9 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. )*
TENET HEALTHCARE CORPORATION
(Name of Issuer)
Common Stock, $0.05 par value per share
(Title of Class of Securities)
Glenview Capital Management
767 Fifth Avenue, 44th Floor
New York, NY 10153
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 7, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☒
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).